Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank95
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P95
Near historical high
vs 2Y Ago
3.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 62.97% |
| Q3 2025 | -137.19% |
| Q2 2025 | -9.67% |
| Q1 2025 | 23.72% |
| Q4 2024 | -39.84% |
| Q3 2024 | -14.38% |
| Q2 2024 | 68.01% |
| Q1 2024 | 8.40% |
| Q4 2023 | 17.63% |
| Q3 2023 | -6.73% |
| Q2 2023 | 39.08% |
| Q1 2023 | -74.27% |
| Q4 2022 | -2.47% |
| Q3 2022 | 21.47% |
| Q2 2022 | -50.38% |
| Q1 2022 | 28.53% |
| Q4 2021 | -55.17% |
| Q3 2021 | -84.57% |
| Q2 2021 | -12.33% |
| Q1 2021 | 17.36% |
| Q4 2020 | -2.81% |
| Q3 2020 | -4.77% |
| Q2 2020 | 1.10% |
| Q1 2020 | -35.07% |
| Q4 2019 | 0.00% |
| Q3 2019 | -3.86% |
| Q2 2019 | 0.00% |
| Q1 2019 | 40.59% |
| Q4 2018 | 0.00% |
| Q3 2018 | -366.36% |
| Q2 2018 | 0.00% |
| Q1 2018 | -135.25% |
| Q4 2017 | 0.00% |
| Q3 2017 | 65.19% |
| Q2 2017 | 0.00% |
| Q1 2017 | -3.57% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |